Teva Pharmaceutical Industries (TEVJF) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Teva Pharmaceutical Industries (TEVJF) over the last 17 years, with Q4 2025 value amounting to 0.19.
- Teva Pharmaceutical Industries' Equity Ratio rose 4196.69% to 0.19 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.19, marking a year-over-year increase of 4196.69%. This contributed to the annual value of 0.19 for FY2025, which is 4196.69% up from last year.
- Per Teva Pharmaceutical Industries' latest filing, its Equity Ratio stood at 0.19 for Q4 2025, which was up 4196.69% from 0.18 recorded in Q3 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Equity Ratio registered a high of 0.24 during Q3 2021, and its lowest value of 0.14 during Q4 2024.
- In the last 5 years, Teva Pharmaceutical Industries' Equity Ratio had a median value of 0.19 in 2025 and averaged 0.19.
- As far as peak fluctuations go, Teva Pharmaceutical Industries' Equity Ratio crashed by 2680.1% in 2024, and later soared by 4196.69% in 2025.
- Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Equity Ratio stood at 0.24 in 2021, then decreased by 17.18% to 0.2 in 2022, then dropped by 4.33% to 0.19 in 2023, then dropped by 26.8% to 0.14 in 2024, then skyrocketed by 41.97% to 0.19 in 2025.
- Its last three reported values are 0.19 in Q4 2025, 0.18 for Q3 2025, and 0.17 during Q2 2025.